COMMUNIQUÉS West-GlobeNewswire

Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand
27/12/2025
Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know Before Choosing a Telehealth NAD+ Provider in 2026 ENCINITAS, Dec. 27, 2025 (GLOBE NEWSWIRE) -- [...]
Best Fat Burner For Men 2026: Effective Fat Burning Supplements For Men’s Belly Fat Launched By Wolfson Brands Ltd
27/12/2025
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements to boost metabolism, control appetite & burn fat. New York City, NY, Dec. 26, 2025 (GLOBE NEWSWIRE) -- [...]
Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026
27/12/2025
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable and needle-free formats. SCOTTSDALE, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for [...]
Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts
27/12/2025
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage Resolution Reshapes Weight Loss Medication Landscape Bluffdale, Dec. 26, 2025 (GLOBE [...]
Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options
27/12/2025
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to Regulations SAN DIEGO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- As the post-holiday period brings renewed interest in [...]
Best Semaglutide Options for 2026: New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
27/12/2025
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists Compounded Options Alongside New FDA-Approved Oral Pathway Los Angeles, Dec. 26, 2025 (GLOBE NEWSWIRE) -- [...]
Best Peptides for Weight Loss 2026: Industry Analysis Examines Compounded GLP-1 Telehealth Access and Pricing Transparency
26/12/2025
Sprout Health Serves as Case Study for Provider Model Structure, Program Costs, and FDA-vs-Compounded Disclosure Standards Orlando, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational [...]
Outlook Therapeutics Announces New Employment Inducement Grants
26/12/2025
ISELIN, N.J., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, [...]
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)
26/12/2025
NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Southpoint Capital Advisors LP (“Southpoint”), acting on behalf of certain Southpoint funds for which it serves as investment manager, announces that on December 24, 2025, [...]
MEDIROM Partners with World
26/12/2025
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex Blania TOKYO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters:Minato-ku, [...]
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
26/12/2025
DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc . ® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that on December 24, 2025, it received a notice from [...]
Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations
26/12/2025
While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn LCDs, Celularity CEO Dr. Robert J. Hariri welcomed the recent action taken under the leadership of [...]
Capilea Mexico Unveils New Insights on Surge of US Patients Choosing Mexico for Hair Transplants
26/12/2025
Mexico: The New Hub for US Hair Transplants Tijuana, BC, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Capilea Mexico , a leading hair restoration clinic network in Latin America, today unveiled new insights highlighting Mexico’s [...]
Can-Fite Granted Brazilian Patent for Treatment of Sexual Dysfunction
26/12/2025
RAMAT GAN, Israel, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and [...]
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
26/12/2025
NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced that its Board of Directors has authorized a cash [...]
IBA signe un contrat pour l’installation d’une solution Proteus®PLUS à trois salles au Seoul St. Mary’s Hospital
26/12/2025
Louvain-la-Neuve, Belgique, le 26 décembre 2025 - IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélération de particules et principal fournisseur de solutions de protonthérapie pour le [...]
IBA signs contract for a three-room Proteus®PLUS solution to be installed at the Seoul St. Mary’s Hospital
26/12/2025
Louvain-La-Neuve, Belgium, December 26, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the [...]
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
24/12/2025
RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “ Company ” or “ XTL ”), announced today that it has received a notification letter from The Listing [...]
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
24/12/2025
PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity [...]

Pages